1-3 of 3
Pascal Klaus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of marstacimab treatment in adolescent participants with Hemophilia A or B without inhibitors compared with prior routine prophylaxis: Results from the phase 3 BASIS trial

Free
Anthony Chan, Andrew Palladino, Priya Patel, Pascal Klaus, Pengling Sun, Carrie Turich Taylor, Sangeeta Raje, Francesca Biondo
Journal: Blood
Blood (2025) 146 (Supplement 1): 4845.
https://doi.org/10.1182/blood-2025-4845
Published: 2025
Journal Articles

Characterization of participants with elevated bleeding rates responding to prophylactic marstacimab treatment in the phase 3 BASIS trial

Free
Young-Shil Park, Fahri Sahin, Laurent Frenzel, Davide Matino, Pascal Klaus, Priya Patel, Pengling Sun, Carrie Turich Taylor, Andrew Palladino
Journal: Blood
Blood (2025) 146 (Supplement 1): 4838.
https://doi.org/10.1182/blood-2025-4838
Published: 2025
Journal Articles

Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial

Free
Andrew D. Leavitt, Kaan Kavakli, Laurent Frenzel, Ali Bülent Antmen, Margareth Ozelo, Davide Matino, Hazza Alzahrani, Barbara A. Konkle, Steven W. Pipe, Jerome M. Teitel, Li-Jung Tseng, Annie F. Fang, Florence Ganne, Gregory Dirusso, Jeremy Rupon, Pascal Klaus, Jasmine Healy, Delphine Agathon, Francesca Biondo, Frank Plonski
Journal: Blood
Blood (2024) 144 (Supplement 1): 1053.
https://doi.org/10.1182/blood-2024-208486
Published: 2024